Retrognathia
Conditions
Interventions
This is a controlled, double-blind clinical study with 2 arms. A total of 26 volunteers who meet the eligibility criteria will be allocated into 2 groups according to the type of hyaluronic acid used:
instructions, with Restylane® Shaype using 27G x 3/4"
needles and Juvederm® Volux using 27G x 1/2"
needles, both supplied in their respective packaging. The chin will be marked and divided in half, creating one central injection point and one on each side (approximately 1 centimeter from the centra
Sponsors
Centro Universitário Ingá - UNINGÁ
Centro Universitário Ingá - UNINGÁ
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Volunteers with complaint of chin retrusion, classified as levels II - III on the Galderma chin retrusion scale (GCRS); no previous aesthetic treatments in the mental region.
Exclusion criteria
Exclusion criteria: Volunteers who are pregnant or breastfeeding; with hypersensitivity to hyaluronic acid; who have received aesthetic treatments in the medial and lower region of the face in the last year; who present with autoimmune diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1: It is expected to find a significant augmentation in the chin region after 1 and 3 months, verified through the Galderma Chin Retrusion Scale | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome 2: It is expected to find a significant increase on patient´s satisfaction with the treatment in the chin region after 1 and 3 months, verified through the FACE-Q Scale;Expected outcome 3: It is expected to do not find any bone changes in the chin region after6 months, verified through the Cone Beam Computerized Tomography | — |
Countries
Brazil
Contacts
Public ContactAndressa El Assad
Centro Universitário Ingá - UNINGÁ
Outcome results
None listed